Neuroventis

Medication adherence is a common, costly challenge for pharma with a direct, negative impact on patient outcomes. There is a particularly high rate of medication non-adherence in patients with neurological conditions which may be attributed to a variety of reasons including forgetfulness, symptom worsening, and lack of empowerment or engagement. Our neurological patient and HCP engagement platform supports pharma companies in offering services and programs to deliver optimal patient outcomes and generate RWD. Our CE and ISO13485 certified platform empowers neurology patients to remotely track and self-manage symptoms, maintain adherence, and improve their outcomes. Real-time insights from the patients’ experiences are shared with HCPs so they can provide data-driven care. Our platform is being used by 15,000+ patients and over 200 HCPs in partnership with four pharmaceutical companies. We fully support patients with migraine and epilepsy and are expanding to Parkinson’s disease, Multiple Sclerosis, Alzheimer’s, and Myasthenia Gravis.